-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EZUbJmPp3uOzn07DDP0c1yq1bqeo7Hs4iqCXfp4QsQwCVXj8PWBPHZo8BaRZpz37 X0253pjEdPogTWxeux+n1g== 0000950135-98-005470.txt : 19981019 0000950135-98-005470.hdr.sgml : 19981019 ACCESSION NUMBER: 0000950135-98-005470 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981016 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-59513 FILM NUMBER: 98727117 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 424B3 1 SUPPLEMENT TO PROSPECTUS DATED SEPTEMBER 18, 1998 1 PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED SEPTEMBER 18, 1998 REGISTRATION NO. 333-59513 [GENZYME CORPORATION LOGO] $250,000,000 PRINCIPAL AMOUNT OF 5 1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2005 6,313,131 SHARES OF GENZYME GENERAL DIVISION COMMON STOCK Genzyme previously issued $250,000,000 principal amount of 5 1/4% convertible subordinated notes due 2005. Holders of these notes can convert principal into shares of Genzyme General Division Common Stock. This prospectus supplement relates to sales of these notes and such shares. A copy of the prospectus dated September 18, 1998 should be delivered to you together with this prospectus supplement. In deciding whether to invest, you should carefully review the information in the prospectus and this prospectus supplement. ------------------------ INVESTING IN THE 5 1/4% CONVERTIBLE SUBORDINATED NOTES AND SHARES OF GENZYME GENERAL DIVISION COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CAREFULLY READ AND CONSIDER THE "RISK FACTORS" BEGINNING ON PAGE 3 OF THE PROSPECTUS. ------------------------ Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense. THE DATE OF THIS PROSPECTUS SUPPLEMENT IS OCTOBER 16, 1998. Genzyme Corporation - One Kendall Square - Cambridge, Massachusetts 02139 - (617) 252-7500 2 SELLING SECURITYHOLDERS The information in the following table is presented as of October 15, 1998 and supersedes in part the information in the table appearing under the heading "Selling Securityholders" in the prospectus:
NUMBER OF PRINCIPAL AMOUNT SHARES OF NUMBER OF SHARES OF OF NOTES GGD STOCK(+) GGD STOCK(+) ISSUABLE BENEFICIALLY PERCENTAGE BENEFICIALLY UPON CONVERSION OF OWNED THAT OF NOTES OWNED PRIOR TO THE NOTES THAT NAME MAY BE SOLD OUTSTANDING OFFERING MAY BE SOLD(1) ---- ---------------- ------------- ---------------- --------------------- BancBoston Robertson Stephens......... $2,900,000 1.2 0 73,232 Chartwell Dividend & Income Fund, Inc................................. 1,000,000 * 0 25,252 Delta Air Lines Master Trust (Calamos Asset Management, Inc.)............. 2,775,000 1.1 0 70,075 Delta Air Lines Master Trust (Oaktree Capital Management, LLC)(2)......... 1,250,000 * 0 31,565 McMahan Securities Company, L.P....... 20,000 * 0 505 National Union Fire Insurance Company of Pittsburgh (GEM Capital Management, Inc.)................... 2,500,000 1.0 0 63,131 National Union Fire Insurance Company of Pittsburgh (Zazove Associates)... 1,000,000 * 0 25,252 NationsBanc Montgomery Securities, LLC................................. 5,000,000 2.0 0 126,262 OCM Convertible Trust(3).............. 2,730,000 1.1 0 68,939 Partner Reinsurance Company, Ltd.(4)............................. 540,000 * 0 13,636 Raytheon Company Master Pension Trust(5)............................ 1,460,000 * 0 36,868 State Employees' Retirement Fund of the State of Delaware(6)............ 1,005,000 * 0 25,378 State of Connecticut Combined Investment Funds(7)................. 3,555,000 1.4 0 89,772 Teachers Insurance and Annuity Association of America.............. 4,000,000 1.6 0 101,010 Vanguard Convertible Securities Fund, Inc.(8)............................. 2,360,000 * 0 59,595
- --------------- + Genzyme General Division Common Stock. * Less than 1%. (1) Assumes conversion of the full amount of notes held by such holder at the initial rate of 25.2525 shares of Genzyme General Division Common Stock per $1,000 in principal amount of the notes. The conversion rate and the number of shares of Genzyme General Division Common Stock issuable upon conversion of the notes may be adjusted under certain circumstances. See "DESCRIPTION OF NOTES -- Conversion Rights" beginning on page 16 of the prospectus. Accordingly, the number of shares of Genzyme General Division Common Stock issuable upon conversion of the notes may increase or decrease from time to time. Under the terms of Genzyme's Indenture dated May 22, 1998, fractional shares will not be issued upon conversion of the notes; cash will be paid instead of fractional shares, if any. (2) Represents an additional $150,000 principal amount of the notes acquired after September 11, 1998. (3) Represents an additional $330,000 principal amount of the notes acquired after September 11, 1998. (4) Represents an additional $40,000 principal amount of the notes acquired after September 11, 1998. (5) Represents an additional $170,000 principal amount of the notes acquired after September 11, 1998. (6) Represents an additional $115,000 principal amount of the notes acquired after September 11, 1998. (7) Represents an additional $405,000 principal amount of the notes acquired after September 11, 1998. (8) Represents an additional $290,000 principal amount of the notes acquired after September 11, 1998. 2
-----END PRIVACY-ENHANCED MESSAGE-----